John Y. Kim, M.D., Ph.D. - Publications

Neuro-oncology Kaiser-Permanente, Oakland 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Doucette TA, Yang Y, Pedone C, Kim JY, Dubuc A, Northcott PD, Taylor MD, Fults DW, Rao G. WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma. Neurosurgery. 70: 1003-10; discussion . PMID 22037313 DOI: 10.1227/NEU.0b013e31823e5332  0.48
2008 Castellino RC, De Bortoli M, Lu X, Moon SH, Nguyen TA, Shepard MA, Rao PH, Donehower LA, Kim JYH. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D Journal of Neuro-Oncology. 86: 245-256. PMID 17932621 DOI: 10.1007/s11060-007-9470-8  0.48
2007 De Bortoli M, Castellino RC, Skapura DG, Shen JJ, Su JM, Russell HV, Hicks MJ, Man TK, Kim JY. Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases. European Journal of Cancer (Oxford, England : 1990). 43: 1308-17. PMID 17467979 DOI: 10.1016/j.ejca.2007.02.008  0.48
2006 De Bortoli M, Castellino RC, Lu XY, Deyo J, Sturla LM, Adesina AM, Perlaky L, Pomeroy SL, Lau CC, Man TK, Rao PH, Kim JY. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8. Bmc Cancer. 6: 223. PMID 16968546 DOI: 10.1186/1471-2407-6-223  0.48
2005 Sturla LM, Cowan CW, Guenther L, Castellino RC, Kim JY, Pomeroy SL. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death. Cancer Research. 65: 5683-9. PMID 15994942 DOI: 10.1158/0008-5472.CAN-04-2283  0.48
2004 Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, Rowitch DH, Kohane IS. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes & Development. 18: 629-40. PMID 15075291 DOI: 10.1101/gad.1182504  0.48
2004 Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JY, Tamayo P, Pomeroy SL. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 994-8. PMID 14970184 DOI: 10.1200/JCO.2004.03.036  0.48
2003 Kim JY, Nelson AL, Algon SA, Graves O, Sturla LM, Goumnerova LC, Rowitch DH, Segal RA, Pomeroy SL. Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice. Developmental Biology. 263: 50-66. PMID 14568546 DOI: 10.1016/S0012-1606(03)00434-2  0.48
2003 Nelson AL, Algon SA, Munasinghe J, Graves O, Goumnerova L, Burstein D, Pomeroy SL, Kim JY. Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. Journal of Neuro-Oncology. 62: 259-67. PMID 12777077 DOI: 10.1023/A:1023339902812  0.48
2002 Kim JY, Koralnik IJ, LeFave M, Segal RA, Pfister LA, Pomeroy SL. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro-Oncology. 4: 165-70. PMID 12084346 DOI: 10.1215/S1522851701000606  0.48
2002 Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415: 436-42. PMID 11807556 DOI: 10.1038/415436a  0.48
Show low-probability matches.